当前位置:首页 - 行情中心 - 海森药业(001367) - 财务分析

海森药业

(001367)

  

流通市值:8.70亿  总市值:34.15亿
流通股本:3870.89万   总股本:1.52亿

海森药业(001367)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润0.31亿元,每股收益0.31元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益138054.42万元,未分配利润48242.69万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产150593.41万元,负债12538.99万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入118,478,458.16471,510,162.35320,044,589.93210,636,845.09
营业总成本83,568,452.19333,026,439.58220,992,411.05145,296,234.7
营业利润35,812,754.05142,045,910.94101,629,819.9767,372,621.37
利润总额36,188,906.99141,785,438.94100,257,493.8367,000,571.39
净利润31,212,181.59122,557,731.6586,950,138.5858,040,447.95
其他综合收益----
综合收益总额31,212,181.59122,557,731.6586,950,138.5858,040,447.95
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计1,243,053,811.771,257,624,341.821,199,091,801.921,191,083,051.87
非流动资产合计262,880,282.35228,367,402.78200,348,612.92186,867,610.79
资产总计1,505,934,094.121,485,991,744.61,399,440,414.841,377,950,662.66
流动负债合计106,716,589122,040,00373,551,569.1582,416,666.24
非流动负债合计18,673,323.319,797,084.422,922,312.5621,395,976.01
负债合计125,389,912.3141,837,087.496,473,881.71103,812,642.25
归属于母公司股东权益合计1,380,544,181.821,344,154,657.21,302,966,533.131,274,138,020.41
股东权益合计1,380,544,181.821,344,154,657.21,302,966,533.131,274,138,020.41
负债和股东权益合计1,505,934,094.121,485,991,744.61,399,440,414.841,377,950,662.66
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计104,381,799.72386,608,648.58289,109,710.07188,965,664.6
经营活动现金流出小计63,923,012.35219,452,372.68168,539,885.06113,820,004.18
经营活动产生的现金流量净额40,458,787.37167,156,275.9120,569,825.0175,145,660.42
投资活动现金流入小计65,213,663.34373,000,531.530,174,271.23-
投资活动现金流出小计281,911,894.16434,748,175.31332,172,088279,891,797.73
投资活动产生的现金流量净额-216,698,230.82-61,747,643.81-301,997,816.77-279,891,797.73
筹资活动现金流入小计-25,464,450--
筹资活动现金流出小计-35,855,62533,407,191.4633,113,521.46
筹资活动产生的现金流量净额--10,391,175-33,407,191.46-33,113,521.46
汇率变动对现金及现金等价物的影响837,720.092,676,176.571,732,644.011,784,487.98
现金及现金等价物净增加额-175,401,723.3697,693,633.66-213,102,539.21-236,075,170.79
期末现金及现金等价物余额859,080,388.921,034,482,112.28723,685,939.41700,713,307.83
TOP↑